期刊文献+

载灯盏花素介孔二氧化硅的制备及其体外溶出考察 被引量:4

Preparation and in vitro Dissolution Study of Mesoporous Silica Nanoparticles Loading Breviscapine
在线阅读 下载PDF
导出
摘要 目的:制备载灯盏花素介孔二氧化硅(BRE-MSN)以提高药物的体外溶出度。方法:以吸附法将灯盏花素负载于介孔二氧化硅,通过氮气吸附-解吸试验、透射电镜(TEM)、差示扫描量热(DSC)、X-射线衍射(XRD)分析对其进行性质表征,同时对制剂的稳定性和释药行为进行考察。结果:所制BRE-MSN的载药量为(37.47±1.38)%;空白MSN的比表面积为1139.8m2·g-1,BRE-MSN的比表面积为521.9 m2·g-1;药物以无定形态存在于载体中,且拥有较好的稳定性;体外释放试验显示,累计溶出率最高达到了93.74%。结论:本方法成功制备得到了载药量高、性质稳定的BRE-MSN且显著提高了BRE的水溶性和溶出速率,为解决BRE的水难溶性提供了一种有效的方法。 Objective:To prepare mesoporous silica nanoparticles(MSN)loading breviscapine(BRE-MSN)to improve the dissolution of breviscapine.Methods:MSN was used as the carrier to load BRE by the adsorption method.BRE-MSN was characterized by nitrogen adsorption test,transmission electron microscope,differential scanning calorimetry and X-ray diffraction.And then,stability and in vitro dissolution study of BRE-MSN were performed.Results:The drug loading of BRE-MSN was(37.47±1.38)%.The specific surface area of the blank MSN and BRE-MSN was 1139.8 m2·g-1 and 521.9 m2·g-1,respectively.BRE-MSN had good stability and the drug state in the MSN was not crystal.The accumulate release rate of BRE-MSN could achieve to 93.74%.Conclusion:BRE-MSN with high drug loading and good stability was prepared successfully,which can significantly improve the solubility and dissolution rate of BRE.The study provides an effective method for solving the water-insolubility of BRE.
作者 陈敏燕 杨刚 吴飞华 原永芳 Chen Minyan;Yang Gang;Wu Feihua;Yuan Yongfang(Department of Pharmacy,the Ninth People’s Hospital Affiliated to Medical School,Shanghai Jiao Tong University,Shanghai 200011,China)
出处 《中国药师》 CAS 2020年第3期457-461,共5页 China Pharmacist
基金 上海交通大学“医工交叉基金项目”(编号:YG2016QN08).
关键词 灯盏花素 介孔二氧化硅 稳定性 体外溶出 Breviscapine Mesoporous silica nanoparticles Stability In vitro release
  • 相关文献

参考文献5

二级参考文献27

  • 1蒋学华,李素华,兰轲,杨俊毅,周静.灯盏花素在家犬体内的药代动力学[J].药学学报,2003,38(5):371-373. 被引量:67
  • 2KHOO S M,ANDREW J H,CHRISTOPHER H P,et al.Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine[J].Int J Pharm,1998,167(1-2):155-164.
  • 3汪明性.新编实用药物学[M].北京:科学出版社,2000.277.
  • 4GIANNAKOU S A, DALLAS P P, REKKAS D M, et al. In vitro evaluation of nimodipine permeation through human epidermis using response surface methodology [ J]. lnt J Pharm,2002,241 ( 1 ) :27-34.
  • 5KARAVAS E, KTISTIS G, XENAKIS A, et al. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone [ J ] . Eur J Pharm Biopharm, 2006,63 ( 2 ) : 103-114.
  • 6WANG S. Ordered mesoporous materials for drug delivery [ J ]. Microporous and Mesoporous Materials, 2009,117 ( 1 ) : 1-9.
  • 7VALLET R M, BALAS F, ARCOS D. Mesoporous materials for drug delivery[J].Angewandte Chemie International Edition, 2007,46(40) :7548-7558.
  • 8SLOWING I I, VIVERO-ESCOTO J L, WU C, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers [ J ] . Adv Drug Deliv Rev, 2008,60 (11) :1278-1288.
  • 9SIERRA L, VALANGE S, GUTH J. Formation mechanism and morphology of mesoporous SBA-16 type silica particles prepared with the triblock copolymer surfactant PEO140 PPO39 PEO140 [ J]. Microporous and Mesoporous Materials, 2009,124 ( 1 ) : 100-109.
  • 10BALLEM MOHAMED A, CORDOBA JOSE M, ODED M. Influence of synthesis temperature on morphology of SBA-16 meso- porous materials with a three-dimensional pore system [ J ]. Microporous and Mesoporous Materials, 2010,129( 1 ) :106-111.

共引文献136

同被引文献22

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部